| Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
|---|
| 07/25/2007 | CN1328284C Stabilized silver sulfonate complex of organo-phosphine, method for synthesizing and use thereof |
| 07/25/2007 | CN1328283C Method of producing ammonium glyphosate |
| 07/25/2007 | CN1328235C Improed process of prepn. of linear aldehydes |
| 07/25/2007 | CN1328230C Transfer hydrogenation process |
| 07/25/2007 | CN1327962C Production of oxygenated products |
| 07/25/2007 | CN101005847A Novel thiazole inhibitors of fructose 1,6-bisphosphatase |
| 07/25/2007 | CN101003550A Nucleotide compound in halogenating adenine class, synthetic method, medical appliction |
| 07/25/2007 | CN101003549A Phosphine compound of possessing plane chirality cyclophane alkyl, synthetic method, and appliction |
| 07/25/2007 | CN101003548A Rosinyl diterpene modified alpha ¿C phosphoramidate, preparation method, and application for anti tumors |
| 07/25/2007 | CN101003547A Gas drying type technique for concentrating soya lecithin |
| 07/25/2007 | CN101003503A Process for the preparation of prostaglandins and analogues thereof |
| 07/24/2007 | US7247740 Reacting perfluoroalkanesulfonic acid directly with dialkyl carbonate to give alkyl perfluoroalkanesulfonate optionally in the presence of a water or alcohol consuming reagent, and preparing an alkyl perfluoroalkanesulfonate with an alkylamine or alkylphosphine to prepare perfluoroalkanesulfonic acid |
| 07/24/2007 | US7247733 By halogen exchange reaction using specific guanidinium, phosphonium or sulfonium catalysts, e.g., diethylaminobis[tris(diethylamino)phosphazenyl]-sulfonium bromide, diethylaminobis(tetramethyl-guanidino)sulfonium bromide and (N,N-dimethylimidazolidino)tetramethyl-guanidinium chloride |
| 07/24/2007 | US7247731 Ligands for metals and improved metal-catalyzed processes based thereon |
| 07/24/2007 | US7247726 Generating chemiluminescence by reaction with peroxidase compound and detection of signal with analyzing compound |
| 07/24/2007 | US7247720 Nucleosides was phosphitylated using O- beta -cyanoethyl-N,N,N',N'-tetraisopropylphosphoramidite and the N-methylimidazole salt of saccharin as activator |
| 07/24/2007 | US7247222 Electrochemical processing cell |
| 07/24/2007 | CA2479846C Phosphonomethoxymethylpurine/pyrimidine derivatives |
| 07/19/2007 | WO2007082104A2 Compounds and methods for the treatment of cancer |
| 07/19/2007 | WO2007080998A1 Cyanato-containing cyclic phosphazenes and process for production thereof |
| 07/19/2007 | WO2007080812A1 Process for production of phosphate polymer |
| 07/19/2007 | WO2006105372A3 Alkynyl pyrrolopyrimidines and related analogs as hsp90-inhibitors |
| 07/19/2007 | WO2006042751A3 Formulations containing alkylphosphocholines using novel negative charge carriers |
| 07/19/2007 | US20070167653 by converting an acylphosphine oxide which is in the form of a melt or in dispersed form into the solid state of aggregation with mechanical stress, shearing/internal agitation of the melt; acylphosphine oxide is 2,4,6-trimethylbenzoyldiphenylphosphine, for example |
| 07/19/2007 | US20070167620 N-allyloxycarbonylmethylenetriphenphosphino- (3S,4S)-3-[(1R)-1-(t-Butyldimethylsilyloxy)ethyl]-4-[(1R)-1-carboxyethyl]- 2-azetidinone; crystallization |
| 07/19/2007 | US20070167591 Alkoxyamines derived from beta-phosphorylated nitroxides, and use thereof for preparing polymerized or non-polymerized mono- or polyalkoxyamines |
| 07/19/2007 | US20070167441 Xanthones, thioxanthones and acridinones as dna-pk inhibitors |
| 07/19/2007 | US20070167412 Halocombstatins and methods of synthesis thereof |
| 07/19/2007 | US20070167409 Compounds and Methods for Treating Toll-Like Receptor 2-Related Diseases and Conditions |
| 07/19/2007 | US20070167392 Nucleosides; RNA interference; gene expression inhibition; for use in therapeutic, diagnostic, and research applications involving gene silencing |
| 07/19/2007 | US20070167390 Double strand compositions comprising differentially modified strands for use in gene modulation |
| 07/19/2007 | US20070167385 for treatment of chronic inflammatory bowel disease, Crohn's disease and ulcerative colitis |
| 07/19/2007 | US20070166705 Invention relates to nucleotide or nucleoside molecules modified by reversible covalent attachment of 3'-OH blocking groups thereto, and which molecules may be used in reactions where blocked nucleotide or nucleoside molecules are required, such as in sequencing reactions, polynucleotide synthesis |
| 07/19/2007 | CA2637027A1 N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use |
| 07/19/2007 | CA2636793A1 Compounds and methods for the treatment of cancer |
| 07/18/2007 | EP1808437A1 Method for producing phosphorus compound having phosphate-phosphonate bond |
| 07/18/2007 | EP1807437A1 Ligands for use in asymmetric hydroformylation |
| 07/18/2007 | EP1807090A2 Process for the preparation of ibandronate |
| 07/18/2007 | EP1509537B1 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such |
| 07/18/2007 | CN1326862C Manufacturing method of phosphate ester |
| 07/18/2007 | CN1326824C Process for reducing fluoride impurities resulting from use of fluorophosphite catalysts |
| 07/18/2007 | CN101001900A Method for producing aromatic compound polymer |
| 07/18/2007 | CN101001857A 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones |
| 07/18/2007 | CN101001530A Methods of administering water-soluble prodrugs of propofol for extended sedation |
| 07/18/2007 | CN100999500A Onitrodazole precursor drug and its preparation process and use |
| 07/17/2007 | US7244764 Methods and compositions for treating amyloid-related diseases |
| 07/17/2007 | US7244718 Derivatives of water insoluble drugs which exhibit good activity and water solubility; producing an anesthetic effect in a dog |
| 07/17/2007 | US7244522 Lubricant for magnetic recording medium and use thereof |
| 07/17/2007 | CA2395558C Intermediates for 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 07/17/2007 | CA2288783C Process for preparing carboxylic acid salts and catalysts useful in such process |
| 07/12/2007 | WO2007079272A2 Diaryl alkylphosphonates and methods for preparing same |
| 07/12/2007 | WO2007079177A2 Novel phytic citrate compounds and process for preparing the same |
| 07/12/2007 | WO2007078859A2 Tetraphosphorus ligands for catalytic hydroformylation and related reactions |
| 07/12/2007 | WO2007078028A1 Salt of carboxyethyl phosphinate ester and flame retardant thermoplastic resin composition containing the same |
| 07/12/2007 | WO2007077201A1 Piperazine compounds with a herbicidal action |
| 07/12/2007 | WO2007026379A3 Novel crystalline forms of risedronate monosodium |
| 07/12/2007 | WO2007021937A3 Unsaturated heterocyclic derivatives |
| 07/12/2007 | US20070161805 Process for Preparation of Diphosphine Compounds and Intermediates for the Process |
| 07/12/2007 | US20070161610 Bipolar trans carotenoid salts and their uses |
| 07/12/2007 | US20070161607 immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists |
| 07/12/2007 | US20070161606 Solid and crystalline ibandronic acid |
| 07/12/2007 | US20070161604 urinary diseases, central nervous diseases, inflammatory diseases, circulatory diseases, cancer, diabetes, immune system disorders and alimentary diseases |
| 07/12/2007 | US20070161602 Phosphonate compounds |
| 07/12/2007 | US20070161594 Compositions and their uses directed to il-4r alpha |
| 07/12/2007 | US20070161593 Compositions and their uses directed to il-4r alpha |
| 07/12/2007 | US20070161542 Ptb1b photoprobes |
| 07/12/2007 | US20070160838 Semiconductor nanocrystal and outer layer including oligomeric polydentate ligand bound to nanocrystal by three or more donor groups, each group independently selected from P, N, P .dbd. O, and N .dbd. O, where each monomeric unit includes donor groups, linking groups, and functional groups; luminescence |
| 07/12/2007 | DE102004052725B4 Verfahren zur Herstellung substituierter Phosphane und nach dem Verfahren hergestellte substituierte Phosphane A process for the preparation of substituted phosphines and substituted phosphines prepared by the process |
| 07/12/2007 | CA2636326A1 Functionalised nanoparticles, their production and use |
| 07/12/2007 | CA2634195A1 Piperazine compounds with a herbicidal action |
| 07/11/2007 | EP1806351A2 Amino acid-derived cyclic phosphonamides and methods of synthesizing the same |
| 07/11/2007 | EP1806350A2 Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents |
| 07/11/2007 | EP1805194A1 Novel bisphosphane catalysts |
| 07/11/2007 | EP1805193A1 Method for the production of substituted phosphanes, and substituted phosphanes produced according to said method |
| 07/11/2007 | EP1805192A2 Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents |
| 07/11/2007 | EP1805191A1 Phosphorylated polyphenols as colour-stable agents |
| 07/11/2007 | EP1805107A2 Process for the preparation of highly purified, dialkyl phosphinic acids |
| 07/11/2007 | EP1599487B1 Phosphinic acid analogs of glutamate |
| 07/11/2007 | EP1594550A4 Chelating agents with lipophilic carriers |
| 07/11/2007 | EP1389174B1 Preparation and use of diols |
| 07/11/2007 | CN1997616A Minimization of ligand degradation products, of reversion of same to useful phosphine ligands |
| 07/11/2007 | CN1995048A Adefovir dipivoxil CHARIOTEER crystallographic form and preparation method thereof |
| 07/11/2007 | CN1995047A Bidentate chiral phosphine complex intermediate with C2 symmetrical axle and its preparation method |
| 07/11/2007 | CN1995046A Bidentate chiral phosphine complex with C2 symmetrical axle |
| 07/11/2007 | CN1995045A Transition metal catalysts |
| 07/11/2007 | CN1995025A Preparation and uses of triaza benzophenone cluster compound |
| 07/11/2007 | CN1325506C Allan phosphonic acid as bone re-absorption inhibitor and its physiologically acceptable salt and their prepn |
| 07/10/2007 | US7241917 for treatment of viral infection, tumor, AIDS, fever, ache, and constipation, improvement of immunity, kidney function, neural regulation and physical recovery |
| 07/10/2007 | US7241911 Niobium compound |
| 07/10/2007 | US7241882 Polyamide nucleic acid derivatives, and agents, and processes for preparing them |
| 07/10/2007 | US7241790 For wound healing in a warm blooded vertebrate |
| 07/10/2007 | US7241745 Pyridyl alkene and pyridyl alkine acid amides as cytostatics and immunosupressives |
| 07/10/2007 | US7241715 Dianionic chelating ligands with a bridged-bis-bi-aryl structure; For catalytic polymerization of ethylene/olefin copolymers |
| 07/10/2007 | US7241601 Bioconversion of terfenadine with a microorganism culture of Absidia corymbifera to obtain a racemic mixture of fexofenadine; specificity of the bioconversion with these microorganisms, good yield and little or no by-products |
| 07/10/2007 | CA2199401C Pyrimido[5,4-d]pyrimidines, medicaments comprising these compounds, their use and processes for their preparation |
| 07/10/2007 | CA2128706C Polyunsaturated fatty acid based drugs, in particular docosahexaenoic acid, as platelet aggregation inhibitors and against essential fatty acid deficiencies of the brain |
| 07/10/2007 | CA2087818C Oligonucleotide analogs, their preparation and use |
| 07/05/2007 | WO2007074926A1 Method for producing polymerizable phosphate ester |
| 07/05/2007 | WO2007074915A1 Water-soluble benzoazepine compound and its pharmaceutical composition |
| 07/05/2007 | WO2007074475A2 Novel polymorphic forms of ibandronate |